Results 251 to 260 of about 413,339 (385)

Mitigation of Doxorubicin Cardiotoxicity With Synergistic miRNA Combinations Identified Using Combinatorial Genetics en masse (CombiGEM). [PDF]

JACC CardioOncol
Higashikuni Y, Platt C, Hastings MH, Chen WCW, Guerra JRB, Tokuyama T, Torizal FG, Liu W, Obana T, Bayer AL, Whipple H, Kuznetsov A, Yeri A, Turissini C, Kitchen RR, Shibayama K, Matsumura T, Takeda N, Uosaki H, Asnani AH, Lu TK, Rosenzweig A.   +21 more
europepmc   +1 more source

A phase II trial of dose-escalated doxorubicin and ifosfamide/mesna in patients with malignant mesothelioma

, 1994
Luc Dirix, Jan P. van Meerbeeck, D. Schrijvers, B. Corthouts, A. Prové, Eric Van Marck, P. Vermeire, A.T. van Oosterom   +7 more
openalex   +1 more source

Cell Membrane‐Coated Lipid Nanoparticles for Drug Delivery

Aggregate, EarlyView.
This review highlights recent progress in cell membrane‐coated lipid nanoparticles (CMC‐LNPs), focusing on their design, preparation methods, functional integration, and biomedical applications. It discusses various types of LNPs and coating strategies, characterization techniques, therapeutic functions, and applications.
Moataz B. Zewail, Guangze Yang, Yilong Fan, Yue Hui, Chun‐Xia Zhao, Yun Liu   +5 more
wiley   +1 more source

Comparison of outcomes in feline intermediate- to large-cell lymphoma treated with CMOP (cyclophosphamide, mitoxantrone, vincristine and prednisolone) instead of CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone). [PDF]

J Feline Med Surg
Lai NA, Nguyen SM, Todd JE, Langova V, Bavcar S, Blaxill JE, Yu S, White JD.   +7 more
europepmc   +1 more source

Harnessing the Biological Responses Induced by Nanomaterials for Enhanced Cancer Therapy

Aggregate, EarlyView.
Nanomaterial (NM)‐induced toxicity can be strategically repurposed for cancer therapy. This review summarizes the mechanism by which NMs selectively activate specific cellular processes to regulate cell fate independently. We also discussed how NMs‐induced biological responses can be leveraged as therapeutic strategies for cancer treatment.
Liting Wang, Hao Fu, Jiangtao Lin, Meng Zhao, Chuanrong Chen, Hongze Liao, Yourong Duan   +6 more
wiley   +1 more source

Prevention of Heart Failure Induced by Doxorubicin with Early Administration of Dexrazoxane (PHOENIX Study): dose response and time course of dexrazoxane-induced degradation of topoisomerase 2b. [PDF]

Cardiooncology
Chang HM, Hsu JY, Ahn C, Yeh ETH.
europepmc   +1 more source

Supramolecular Assembly of Triterpenoids: Current State and Biomedical Perspectives

Aggregate, EarlyView.
Triterpenoids serve as both exceptional molecular motifs for supramolecular assembly and versatile therapeutic agents, offering broad biological functions to improve health outcomes and enhance treatment efficacy. This review comprehensively summarizes recent advances in triterpenoid‐based supramolecular systems, including their roles as functional ...
Jie Zhong, Juan C. Mareque‐Rivas, Xinmiao Lan, Yu‐Xiong Su   +3 more
wiley   +1 more source

Systematic review of transarterial chemoembolization for desmoid tumors: a promising locoregional treatment for challenging tumor. [PDF]

Discov Oncol
Alaseem A, Alsaikhan N, AlSudairi AM, Alsehibani YA, Alhuqbani MN, Aldosari ZA, Aldosari OA, Almuhanna A, Alshaygy IS.   +8 more
europepmc   +1 more source

Protracted drug infusions in cancer treatment: An appraisal of 5-fluorouracil, doxorubicin, and platinums

, 1993
Eduardo Delaflor–Weiss, Beatrice Uziely, Franco M. Muggia   +2 more
openalex   +1 more source

OK-432 and 5-fluorouracil, doxorubicin, and mitomycin C (FAM-P) versus FAM chemotherapy in patients with curatively resected gastric carcinoma [PDF]

, 1998
Siyoung Kim, Ho C. Park, Choong Yoon, Hwi Joong Yoon, Yong Mook Choi, Kyung S. Cho   +5 more
openalex   +1 more source